rs72647302

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152419.3(HGSNAT):​c.493+46G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0469 in 1,586,514 control chromosomes in the GnomAD database, including 2,060 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 115 hom., cov: 32)
Exomes 𝑓: 0.048 ( 1945 hom. )

Consequence

HGSNAT
NM_152419.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.23

Publications

2 publications found
Variant links:
Genes affected
HGSNAT (HGNC:26527): (heparan-alpha-glucosaminide N-acetyltransferase) This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. [provided by RefSeq, Jan 2009]
HGSNAT Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 3
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • mucopolysaccharidosis type 3C
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Genomics England PanelApp, Ambry Genetics, G2P
  • retinitis pigmentosa 73
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 8-43159090-G-T is Benign according to our data. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-43159090-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 262647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0502 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HGSNATNM_152419.3 linkc.493+46G>T intron_variant Intron 4 of 17 ENST00000379644.9 NP_689632.2 Q68CP4-2Q8IVU6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HGSNATENST00000379644.9 linkc.493+46G>T intron_variant Intron 4 of 17 2 NM_152419.3 ENSP00000368965.4 Q68CP4-2
HGSNATENST00000520704.1 linkn.343+46G>T intron_variant Intron 4 of 9 1 ENSP00000429109.1 E5RJC4
HGSNATENST00000517319.1 linkn.*62+46G>T intron_variant Intron 3 of 4 4 ENSP00000430032.1 E5RH11

Frequencies

GnomAD3 genomes
AF:
0.0331
AC:
5032
AN:
152022
Hom.:
115
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00964
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.0373
Gnomad ASJ
AF:
0.0248
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0112
Gnomad FIN
AF:
0.0313
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0516
Gnomad OTH
AF:
0.0258
GnomAD2 exomes
AF:
0.0324
AC:
7662
AN:
236598
AF XY:
0.0327
show subpopulations
Gnomad AFR exome
AF:
0.00867
Gnomad AMR exome
AF:
0.0258
Gnomad ASJ exome
AF:
0.0223
Gnomad EAS exome
AF:
0.000404
Gnomad FIN exome
AF:
0.0301
Gnomad NFE exome
AF:
0.0488
Gnomad OTH exome
AF:
0.0414
GnomAD4 exome
AF:
0.0483
AC:
69335
AN:
1434374
Hom.:
1945
Cov.:
29
AF XY:
0.0476
AC XY:
33815
AN XY:
710990
show subpopulations
African (AFR)
AF:
0.00750
AC:
244
AN:
32532
American (AMR)
AF:
0.0277
AC:
1153
AN:
41584
Ashkenazi Jewish (ASJ)
AF:
0.0202
AC:
516
AN:
25578
East Asian (EAS)
AF:
0.00128
AC:
50
AN:
38998
South Asian (SAS)
AF:
0.0134
AC:
1102
AN:
81966
European-Finnish (FIN)
AF:
0.0308
AC:
1623
AN:
52692
Middle Eastern (MID)
AF:
0.0127
AC:
72
AN:
5664
European-Non Finnish (NFE)
AF:
0.0566
AC:
62064
AN:
1096290
Other (OTH)
AF:
0.0425
AC:
2511
AN:
59070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2859
5718
8578
11437
14296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2378
4756
7134
9512
11890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0331
AC:
5032
AN:
152140
Hom.:
115
Cov.:
32
AF XY:
0.0313
AC XY:
2328
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.00961
AC:
399
AN:
41524
American (AMR)
AF:
0.0372
AC:
568
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0248
AC:
86
AN:
3468
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.0112
AC:
54
AN:
4816
European-Finnish (FIN)
AF:
0.0313
AC:
331
AN:
10580
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0516
AC:
3511
AN:
67990
Other (OTH)
AF:
0.0256
AC:
54
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
235
471
706
942
1177
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0451
Hom.:
75
Bravo
AF:
0.0330
Asia WGS
AF:
0.00693
AC:
26
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 31, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Oct 17, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.17
DANN
Benign
0.54
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72647302; hg19: chr8-43014233; API